How Much Did PyrAmes Raise?
Funding & Key Investors

PyrAmes, a digital health innovator, has secured significant enterprise-level funding, with the most recent capital injection being a major strategic investment. The total funding amount to date is represented by $6M, and the recent financing round contributed $6M to the company's growth trajectory. This latest financing round, dated April 20, 2021, was classified as a Series A, indicating a pivotal stage for the company's scaling and market expansion efforts.

What is PyrAmes?

PyrAmes
ManufacturingTest & Measurement EquipmentMedical Devices & Equipment

Established in 2016 and headquartered in California, PyrAmes is a development-stage digital health company dedicated to revolutionizing healthcare delivery through advanced sensor measurement. The company has engineered a proprietary platform featuring continuous, accurate, wireless, and non-invasive blood pressure monitoring. This innovative technology aims to provide a more accessible and efficient method for health tracking, positioning PyrAmes as a key player in the burgeoning digital health and medical device sectors.

How much funding has PyrAmes raised?

PyrAmes has raised a total of $6M across 1 funding round:

2021

Series A

$6M

Series A (2021): $6M with participation from Keystone Ventures, GSR Ventures, and XTX Ventures

Key Investors in PyrAmes

Keystone Ventures

Keystone Ventures is an investment firm that participated in PyrAmes' Series A funding round. Their involvement suggests a focus on companies with disruptive potential in the healthcare technology sector.

GSR Ventures

GSR Ventures, a notable venture capital firm, has backed PyrAmes' Series A financing. Their investment indicates a strategic interest in early-stage companies driving innovation within the digital health and medtech industries.

XTX Ventures

XTX Ventures is an entity that provided capital for PyrAmes' Series A funding. Their participation highlights a commitment to supporting companies at the forefront of technological advancement in healthcare.

What's next for PyrAmes?

The recent Series A financing signifies a critical juncture for PyrAmes, enabling the company to accelerate its development and scale its operations. This strategic investment is expected to fuel further technological advancements, expand market reach, and solidify its position in the competitive digital health landscape. PyrAmes is poised to leverage this capital to enhance its proprietary platform and drive the adoption of its non-invasive blood pressure monitoring solution, ultimately transforming patient care and health management.

See full PyrAmes company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingMedical Devices & Equipment
Health & Nutrition ProductsManufacturing
Building MaterialsManufacturingFinanceLending & BrokerageRetailFurnitureInsurance
Industrial Machinery & EquipmentManufacturing

Frequently Asked Questions Regarding PyrAmes Financial Insights

What are the most recent funding rounds that PyrAmes has completed, and what were the funding rounds?
PyrAmes has recently completed 1 funding rounds: Series A on Apr 20, 2021.
What is the total amount of funding PyrAmes has raised to date?
PyrAmes has raised a total of $6M in funding to date.
How many funding rounds has PyrAmes completed?
PyrAmes has completed 1 funding rounds.
How much funding did PyrAmes raise in its most recent funding round?
PyrAmes raised $6M in its most recent funding round.
Who are the lead investors in PyrAmes's latest funding round?
The lead investor in PyrAmes's latest funding round was Keystone Ventures. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in PyrAmes's history?
The largest funding round in PyrAmes's history was $6M.
See more information about PyrAmes